PP_1170x120_10-25-21

irritable bowel syndrome with diarrhea

Allergan aims to raise IBS-D awareness

Allergan aims to raise IBS-D awareness

DUBLIN, Ireland — Allergan plc has teamed up with the American Gastroenterological Association (AGA) to launch Toilet Talk, a campaign to help raise awareness about irritable bowel syndrome with diarrhea (IBS-D). The Toilet Talk campaign, in recognition of IBS Awareness Month, aims to reduce the stigma associated with talking about bowel health and urges people

Allergan rolls out IBS drug Viberzi

Allergan rolls out IBS drug Viberzi

DUBLIN, Ireland — Allergan plc has released Viberzi (eluxadoline), a treatment for irritable bowel syndrome with diarrhea (IBS-D), to U.S. pharmacies. The company said Monday that Viberzi, a twice-daily oral medication, relieves the core symptoms of IBS-D: recurrent diarrhea and abdominal pain. Symptom relief was maintained throughout treatment in two pivotal clinical trials. “We are excited about the launch of Viberzi, which